nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—EDNRA—Signaling Pathways—GPR37—Parkinson's disease	0.00145	0.00145	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—PDYN—Parkinson's disease	0.00145	0.00145	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—DRD3—Parkinson's disease	0.00143	0.00143	CbGpPWpGaD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00142	0.00142	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—GSTA4—Parkinson's disease	0.00141	0.00141	CbGpPWpGaD
Sitaxentan—CYP2C19—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00139	0.00139	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—HTR1A—Parkinson's disease	0.00139	0.00139	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—GRM4—Parkinson's disease	0.00138	0.00138	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—TAC1—Parkinson's disease	0.00137	0.00137	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—GRM5—Parkinson's disease	0.00135	0.00135	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—DRD1—Parkinson's disease	0.00134	0.00134	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00133	0.00133	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00133	0.00133	CbGpPWpGaD
Sitaxentan—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00132	0.00132	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—EDN1—Parkinson's disease	0.00131	0.00131	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PENK—Parkinson's disease	0.00131	0.00131	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MAG—Parkinson's disease	0.00131	0.00131	CbGpPWpGaD
Sitaxentan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00131	0.00131	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—DRD3—Parkinson's disease	0.0013	0.0013	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—HTR7—Parkinson's disease	0.00129	0.00129	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—DRD2—Parkinson's disease	0.00129	0.00129	CbGpPWpGaD
Sitaxentan—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00129	0.00129	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—GSTA4—Parkinson's disease	0.00129	0.00129	CbGpPWpGaD
Sitaxentan—CYP2C9—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00127	0.00127	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00126	0.00126	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—MAOB—Parkinson's disease	0.00126	0.00126	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00121	0.00121	CbGpPWpGaD
Sitaxentan—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00121	0.00121	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PDYN—Parkinson's disease	0.00119	0.00119	CbGpPWpGaD
Sitaxentan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00119	0.00119	CbGpPWpGaD
Sitaxentan—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00118	0.00118	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—HTR7—Parkinson's disease	0.00117	0.00117	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—DRD2—Parkinson's disease	0.00117	0.00117	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—RIT2—Parkinson's disease	0.00116	0.00116	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.00115	0.00115	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—HTR2A—Parkinson's disease	0.00115	0.00115	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00114	0.00114	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—GFAP—Parkinson's disease	0.00112	0.00112	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—GRM5—Parkinson's disease	0.00111	0.00111	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—GRK5—Parkinson's disease	0.0011	0.0011	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00109	0.00109	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—TAC1—Parkinson's disease	0.00108	0.00108	CbGpPWpGaD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00106	0.00106	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—DRD1—Parkinson's disease	0.00106	0.00106	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—EDN1—Parkinson's disease	0.00103	0.00103	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—DRD3—Parkinson's disease	0.00102	0.00102	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—HTR1A—Parkinson's disease	0.000993	0.000993	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—GRM4—Parkinson's disease	0.000986	0.000986	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000986	0.000986	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—TAC1—Parkinson's disease	0.000978	0.000978	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—FGF20—Parkinson's disease	0.000974	0.000974	CbGpPWpGaD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000968	0.000968	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—DRD1—Parkinson's disease	0.000959	0.000959	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000955	0.000955	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—ADORA2A—Parkinson's disease	0.000944	0.000944	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—EDN1—Parkinson's disease	0.000939	0.000939	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PENK—Parkinson's disease	0.000935	0.000935	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MAG—Parkinson's disease	0.000935	0.000935	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—CYP2D6—Parkinson's disease	0.000935	0.000935	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—DRD3—Parkinson's disease	0.000929	0.000929	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—HTR7—Parkinson's disease	0.000925	0.000925	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—DRD2—Parkinson's disease	0.000925	0.000925	CbGpPWpGaD
Sitaxentan—CYP2C19—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000922	0.000922	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000905	0.000905	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—INSR—Parkinson's disease	0.000872	0.000872	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000867	0.000867	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PDYN—Parkinson's disease	0.000855	0.000855	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	0.000855	0.000855	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.000852	0.000852	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000848	0.000848	CbGpPWpGaD
Sitaxentan—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000843	0.000843	CbGpPWpGaD
Sitaxentan—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00084	0.00084	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—HTR7—Parkinson's disease	0.00084	0.00084	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—DRD2—Parkinson's disease	0.00084	0.00084	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000837	0.000837	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—FGB—Parkinson's disease	0.000824	0.000824	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—HTR2A—Parkinson's disease	0.000822	0.000822	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HTR1A—Parkinson's disease	0.000819	0.000819	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TAC1—Parkinson's disease	0.000807	0.000807	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—GFAP—Parkinson's disease	0.000804	0.000804	CbGpPWpGaD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000796	0.000796	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—GRM5—Parkinson's disease	0.000795	0.000795	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—DRD1—Parkinson's disease	0.000791	0.000791	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000782	0.000782	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.000779	0.000779	CbGpPWpGaD
Sitaxentan—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000769	0.000769	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—DRD3—Parkinson's disease	0.000766	0.000766	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000756	0.000756	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—EDN1—Parkinson's disease	0.00074	0.00074	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—ADRBK1—Parkinson's disease	0.000716	0.000716	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000713	0.000713	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—COMT—Parkinson's disease	0.000708	0.000708	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000705	0.000705	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	0.000705	0.000705	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	0.000703	0.000703	CbGpPWpGaD
Sitaxentan—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	0.000699	0.000699	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—FGF20—Parkinson's disease	0.000697	0.000697	CbGpPWpGaD
Sitaxentan—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000695	0.000695	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—DRD2—Parkinson's disease	0.000693	0.000693	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HTR7—Parkinson's disease	0.000693	0.000693	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ADORA2A—Parkinson's disease	0.000676	0.000676	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—EDN1—Parkinson's disease	0.000672	0.000672	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	0.000648	0.000648	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000648	0.000648	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.000646	0.000646	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.000643	0.000643	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.000641	0.000641	CbGpPWpGaD
Sitaxentan—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000639	0.000639	CbGpPWpGaD
Sitaxentan—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.000637	0.000637	CbGpPWpGaD
Sitaxentan—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000634	0.000634	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—INSR—Parkinson's disease	0.000624	0.000624	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.000591	0.000591	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—FGB—Parkinson's disease	0.00059	0.00059	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—HTR2A—Parkinson's disease	0.000588	0.000588	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HTR1A—Parkinson's disease	0.000586	0.000586	CbGpPWpGaD
Sitaxentan—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000583	0.000583	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IGF2—Parkinson's disease	0.000581	0.000581	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TAC1—Parkinson's disease	0.000578	0.000578	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—DRD1—Parkinson's disease	0.000566	0.000566	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000562	0.000562	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IGF1R—Parkinson's disease	0.000562	0.000562	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—EDN1—Parkinson's disease	0.000555	0.000555	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000554	0.000554	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—DRD3—Parkinson's disease	0.000549	0.000549	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000514	0.000514	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ADRBK1—Parkinson's disease	0.000512	0.000512	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NGF—Parkinson's disease	0.00051	0.00051	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000507	0.000507	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—DRD2—Parkinson's disease	0.000496	0.000496	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HTR7—Parkinson's disease	0.000496	0.000496	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000488	0.000488	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HTR2A—Parkinson's disease	0.000485	0.000485	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—MCCC1—Parkinson's disease	0.000459	0.000459	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ND3—Parkinson's disease	0.000459	0.000459	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—APOE—Parkinson's disease	0.000451	0.000451	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000445	0.000445	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—OMD—Parkinson's disease	0.000432	0.000432	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—TALDO1—Parkinson's disease	0.000432	0.000432	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000426	0.000426	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000424	0.000424	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000423	0.000423	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.00042	0.00042	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—MCCC1—Parkinson's disease	0.000419	0.000419	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ND3—Parkinson's disease	0.000419	0.000419	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000418	0.000418	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IGF2—Parkinson's disease	0.000416	0.000416	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	0.000409	0.000409	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IGF1R—Parkinson's disease	0.000402	0.000402	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—EDN1—Parkinson's disease	0.000397	0.000397	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—TALDO1—Parkinson's disease	0.000394	0.000394	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—OMD—Parkinson's disease	0.000394	0.000394	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GCH1—Parkinson's disease	0.000391	0.000391	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.00039	0.00039	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—INS—Parkinson's disease	0.000386	0.000386	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000384	0.000384	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	0.000373	0.000373	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NGF—Parkinson's disease	0.000365	0.000365	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GCH1—Parkinson's disease	0.000356	0.000356	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000352	0.000352	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GBA—Parkinson's disease	0.000348	0.000348	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—DBH—Parkinson's disease	0.000348	0.000348	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—FBP1—Parkinson's disease	0.000348	0.000348	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HTR2A—Parkinson's disease	0.000347	0.000347	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—APOE—Parkinson's disease	0.000323	0.000323	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000321	0.000321	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GBA—Parkinson's disease	0.000317	0.000317	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—FBP1—Parkinson's disease	0.000317	0.000317	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—DBH—Parkinson's disease	0.000317	0.000317	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CASP3—Parkinson's disease	0.000287	0.000287	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL6—Parkinson's disease	0.000285	0.000285	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000276	0.000276	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000276	0.000276	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—INS—Parkinson's disease	0.000276	0.000276	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MAPK8—Parkinson's disease	0.000264	0.000264	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.00026	0.00026	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—OMD—Parkinson's disease	0.00026	0.00026	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—DDC—Parkinson's disease	0.000255	0.000255	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000246	0.000246	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTA4—Parkinson's disease	0.000241	0.000241	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000238	0.000238	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000235	0.000235	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—DDC—Parkinson's disease	0.000233	0.000233	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTA4—Parkinson's disease	0.00022	0.00022	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	0.000217	0.000217	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000217	0.000217	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—MAOB—Parkinson's disease	0.000215	0.000215	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000209	0.000209	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000209	0.000209	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000209	0.000209	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CASP3—Parkinson's disease	0.000205	0.000205	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000205	0.000205	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL6—Parkinson's disease	0.000204	0.000204	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	0.000198	0.000198	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—MAOB—Parkinson's disease	0.000196	0.000196	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MAPK8—Parkinson's disease	0.000189	0.000189	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000187	0.000187	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL6—Parkinson's disease	0.000168	0.000168	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	0.00016	0.00016	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CTGF—Parkinson's disease	0.000157	0.000157	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—DDC—Parkinson's disease	0.000154	0.000154	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	0.000146	0.000146	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	0.000146	0.000146	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTA4—Parkinson's disease	0.000145	0.000145	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NQO1—Parkinson's disease	0.000145	0.000145	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CTGF—Parkinson's disease	0.000143	0.000143	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—TH—Parkinson's disease	0.000142	0.000142	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYCS—Parkinson's disease	0.000137	0.000137	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	0.000133	0.000133	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NQO1—Parkinson's disease	0.000132	0.000132	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	0.000131	0.000131	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—TH—Parkinson's disease	0.00013	0.00013	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MAOB—Parkinson's disease	0.000129	0.000129	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYCS—Parkinson's disease	0.000125	0.000125	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—COMT—Parkinson's disease	0.000121	0.000121	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6—Parkinson's disease	0.000121	0.000121	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTP1—Parkinson's disease	0.000121	0.000121	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—MAOA—Parkinson's disease	0.00012	0.00012	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HMOX1—Parkinson's disease	0.000119	0.000119	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ABCB1—Parkinson's disease	0.000114	0.000114	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTM1—Parkinson's disease	0.000111	0.000111	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—COMT—Parkinson's disease	0.00011	0.00011	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTP1—Parkinson's disease	0.00011	0.00011	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—MAOA—Parkinson's disease	0.00011	0.00011	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HMOX1—Parkinson's disease	0.000108	0.000108	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GPX1—Parkinson's disease	0.000106	0.000106	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCB1—Parkinson's disease	0.000104	0.000104	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTM1—Parkinson's disease	0.000101	0.000101	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—MTHFR—Parkinson's disease	9.79e-05	9.79e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GPX1—Parkinson's disease	9.67e-05	9.67e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	9.61e-05	9.61e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CTGF—Parkinson's disease	9.43e-05	9.43e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—APOE—Parkinson's disease	9.12e-05	9.12e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—MTHFR—Parkinson's disease	8.93e-05	8.93e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	8.79e-05	8.79e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NQO1—Parkinson's disease	8.69e-05	8.69e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—TH—Parkinson's disease	8.57e-05	8.57e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—APOE—Parkinson's disease	8.31e-05	8.31e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYCS—Parkinson's disease	8.22e-05	8.22e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—INS—Parkinson's disease	7.79e-05	7.79e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—COMT—Parkinson's disease	7.28e-05	7.28e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTP1—Parkinson's disease	7.25e-05	7.25e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MAOA—Parkinson's disease	7.23e-05	7.23e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HMOX1—Parkinson's disease	7.15e-05	7.15e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—INS—Parkinson's disease	7.1e-05	7.1e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCB1—Parkinson's disease	6.86e-05	6.86e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTM1—Parkinson's disease	6.66e-05	6.66e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GPX1—Parkinson's disease	6.38e-05	6.38e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MTHFR—Parkinson's disease	5.89e-05	5.89e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—APOE—Parkinson's disease	5.48e-05	5.48e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—INS—Parkinson's disease	4.68e-05	4.68e-05	CbGpPWpGaD
